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The promise of using reprogrammed human neurons
for disease modeling and regenerative medicine re-
lies on the ability to induce patient-derived neurons
with high efficiency and subtype specificity. We
have previously shown that ectopic expression of
brain-enriched microRNAs (miRNAs), miR-9/9* and
miR-124 (miR-9/9*-124), promoted direct conversion
of human fibroblasts into neurons. Herewe show that
coexpression of miR-9/9*-124 with transcription fac-
tors enriched in the developing striatum, BCL11B
(also known as CTIP2), DLX1, DLX2, and MYT1L,
can guide the conversion of human postnatal and
adult fibroblasts into an enriched population of neu-
rons analogous to striatal medium spiny neurons
(MSNs). When transplanted in the mouse brain, the
reprogrammed human cells persisted in situ for
over 6 months, exhibited membrane properties
equivalent to nativeMSNs, and extended projections
to the anatomical targets of MSNs. These findings
highlight the potential of exploiting the synergism be-
tween miR-9/9*-124 and transcription factors to
generate specific neuronal subtypes.
INTRODUCTION
The generation of induced pluripotent stem cells (iPSCs) holds
great promise for regenerative medicine and the study of human
diseases (Takahashi and Yamanaka, 2006; Yu et al., 2007).
Nevertheless, creating a reliable in vitro disease model based
on deriving iPSCs from multiple human samples followed by dif-
ferentiation into a specific cell subtype is a lengthy process,
which can be further complicated by the variable and unpredict-
able nature across different iPSC lines (Hu et al., 2010). More-
over, reprogramming somatic cells to iPSCs has been shownto reintroduce the embryonic state and therefore hinders
the prospect of modeling late-onset disorders, although new
methods are being developed that may overcome this barrier
(Lapasset et al., 2011; Miller et al., 2013). Most importantly, cur-
rent differentiation protocols often produce a population of cells
with variable heterogeneity (Soldner and Jaenisch, 2012). By-
passing pluripotency and directly reprogramming readily acces-
sible human tissues, such as skin, into neural cells may offer a
fast and efficient approach to study neurological disorders
(Caiazzo et al., 2011; Pang et al., 2011; Yoo et al., 2011).
Although direct neuronal conversion may offer unique benefits,
this approach is currently limited to a small number of protocols
to specify neuronal subtypes using postnatal or adult human
samples (Caiazzo et al., 2011; Liu et al., 2013; Ring et al.,
2012; Son et al., 2011; Yoo et al., 2011).
MiR-9/9* and miR-124 are critical components of a genetic
pathway that controls the assembly of neuron-specific, ATP-
dependent chromatin remodeling complexes during neural
development (Staahl et al., 2013; Yoo et al., 2009). In addition,
these miRNAs have been shown to play key roles in the differen-
tiation of neural progenitors to mature neurons by regulating the
expression of antineural genes (Makeyev et al., 2007; Packer
et al., 2008; Visvanathan et al., 2007; Xue et al., 2013). Ectopic
expression of miR-9/9*-124 promotes the direct conversion of
human adult fibroblasts toward neurons, a process greatly
enhanced by coexpressing transcription factors, NeuroD2,
ASCL1, and MYT1L, yielding a mixed population of excitatory
and inhibitory neurons (Yoo et al., 2011). It remained unknown,
nonetheless, whether the miR-9/9*-124-mediated neuronal con-
version could yield a homogeneous population of a discrete
neuronal subtype. Since the terminally differentiated state of
neuronal subtypes can be instructed by transcription factors
(Hobert, 2011), we hypothesized that transcription factors en-
riched in distinct brain regions could guide the miRNA-mediated
neuronal reprogramming into a specific neuronal subtype.
In this study, we describe the identification of four transcription
factors, CTIP2, DLX1, DLX2, and MYT1L (CDM), that synergize
with miR-9/9*-124 to generate an enriched population of cells
characteristic of striatal medium spiny neurons (MSNs), theNeuron 84, 311–323, October 22, 2014 ª2014 Elsevier Inc. 311
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Induction of Human Fibroblasts to Striatal Neuronsprimary cell type affected in Huntington’s disease (Albin et al.,
1989). Importantly, this reprogramming relies on the activities
of miR-9/9*-124, since CDM factors alone are ineffective for
neuronal conversion. This combinatorial approach generates a
large number of neurons with a gene expression profile analo-
gous to primary human striatal cells microdissected from post-
mortem brain sections. Furthermore, when transplanted into
the mouse striatum, the reprogrammed neurons display func-
tional properties similar to native MSNs. The high efficiency
and specificity of our approach to directly derive human striatal
MSNswill likely be advantageous inmodeling disorders affecting
MSNs such as Huntington’s disease.
RESULTS
Enhancement of miR-9/9*-124-Mediated
Reprogramming
Wepreviously noticed that a large fraction of cells underwent cell
death when transduced to express miR-9/9*-124 (Yoo et al.,
2011). In an effort to optimize the miR-9/9*-124-mediated
neuronal reprogramming, we tested if coexpression of an antia-
poptotic gene would reduce the number of cells deaths during
neuronal reprogramming. Previous studies have shown that
abrogation of apoptosis could enhance neurogenesis (Sahay
et al., 2011; Zhang et al., 2006) and that overexpression of an
antiapoptotic gene BCL2L1 (also known as Bcl-xL) suppressed
programmed cell death (Alavian et al., 2011; Blo¨mer et al.,
1998). When we incorporated Bcl-xL into our lentiviral vector to
be expressed with miR-9/9*-124 (Supplemental Experimental
Procedures available online), we detected an increased number
of surviving cells by over 40% and significantly improved the re-
programming efficiency (Figure S1). We utilized a doxycycline
(Dox)-inducible promoter to temporarily regulate the expression
of miR-9/9*-124 and Bcl-xL. Our characterization of the Dox-
inducible promoter indicated that the transgene readily became
inactive upon the removal of Dox within 3 days (Figure S2).
We found that the continuous expression of miR-9/9*-124
for approximately 30 days was necessary for stable neuronal
conversion as interrupting the transgene expression at day 15 re-
sulted in a significant reduction in the neuronal conversion (Fig-
ure S2). Accordingly, in tissue culture as well as in experiments
in vivo, we routinely withdrew Dox treatment after 30 days into
reprogramming. Interestingly, we found that endogenous miR-
9/9* and miR-124 were expressed after Dox removal by day 30
as the cells adopted a neuronal fate (Figure S2).
Identification of Transcription Factors to Specify
Striatal Neurons
We focused on transcription factors expressed in the GABAergic
MSNs of the striatum, a clinically relevant neuronal subtype
affected in Huntington’s disease (Albin et al., 1989). Striatum-en-
riched transcription factors were selected based on translational
ribosome affinity purification data for DRD1- or DRD2-positive
MSNs from the mouse striatum (Dougherty et al., 2010) and
gene expression databases from Brainspan (http://brainspan.
org) and Allen Brain Atlas (http://human.brain-map.org/). In or-
der to identify transcription factors that would favor the MSN
fate, we transduced human postnatal fibroblasts with lentivirus312 Neuron 84, 311–323, October 22, 2014 ª2014 Elsevier Inc.to express miR-9/9*-124 and sixteen selected transcription fac-
tors individually and examined by immunostaining the number of
MAP2-positive cells that were also positive for the neurotrans-
mitter GABA and the dopamine- and cAMP-regulated neuronal
phosphoprotein (DARPP-32), a well-documented marker of
MSNs (Arlotta et al., 2008; Lobo et al., 2006; Ouimet and Green-
gard, 1990) (Figures 1A and S3). BCL11B (also known as CTIP2),
a transcription factor critical for the differentiation ofMSNs in vivo
(Arlotta et al., 2008), was the only factor tested with miR-9/9*-
124 to yield DARPP-32-positive neurons (Figure 1A). Further-
more, when miR-9/9*-124 were combined with DLX1 and
DLX2, previously shown to be important for terminal differentia-
tion of MSNs (Anderson et al., 1997), we detected a large per-
centage of GABAergic neurons (72.3% of MAP2-positive cells)
(Figure 1A). It is interesting to note that MYT1L, which has previ-
ously been used by our group and others to enhance direct
neuronal reprogramming with other factors (Pang et al., 2011;
Yoo et al., 2011), significantly increased the number of MAP2-
positive cells when tested alone with miR-9/9*-124 (Figures 1A
and S3). Importantly, single transcription factors tested without
miR-9/9*-124 did not induce MAP2-positive cells (data not
shown).
Immunostaining Analysis of Neuronal Markers
Based on our initial screening of individual transcription factors,
we asked if the combination of CTIP2, DLX1, DLX2 (DLX1/2), and
MYT1L (collectively termed CDM) would synergize with miR-9/
9*-124 to generate MSN-like cells (Figure 1A). We first deter-
mined if miR-9/9*-124 with CDM (miR-9/9*-124-CDM) would
robustly generate neurons by examining the expression of gen-
eral neuronal markers, MAP2, TUBB3 (also known as b-III
tubulin), and NeuN (Figure 1B). Counting random fields of view
revealed that approximately 90% of DAPI-positive cells were
MAP2-positive (n = 207), 87% TUBB3-positive (n = 328), and
84% NeuN-positive (n = 328) at 5 weeks posttransduction (Fig-
ure 1C). The converted cells also expressed proteins important
for neuronal function, including voltage-gated sodium channels
(Figure 1D, left) and Synapsin 1 (Figure 1D, right). The neuronal
conversion was dependent on miR-9/9*-124 as transducing
human fibroblasts with CDM factors alone was ineffective in
generating neurons (0.3% MAP2-positive, n = 343) (Figure 1E).
Moreover, expression of CDM in human fibroblasts did not
induce the expression of endogenous neural microRNAs such
as miR-9/9*, miR-124, or miR-132 (Figure S4).
Detection of Markers of Medium Spiny Neurons
We found that the majority of the converted cells were
GABAergic neurons (90% of MAP2-positive, n = 474) assayed
by immunostaining for GABA (Figure 1F, top left, and S5, top,
for larger overview) and GAD67 (Figures 1F, top right, and S5),
without VGLUT1-positive (a marker for glutamatergic neurons)
cells within the population of reprogrammed neurons (0.75% of
MAP2-positive cells, n = 400; Figure S6). Furthermore, we found
that a large fraction of converted neurons (70% of MAP2-posi-
tive, n = 474) expressed DARPP-32 (Figures 1G and S7 for
view of GABAergic DARPP-32-positive cells) and expressed
FOXP1 and DLX5 (Figure 1F, bottom left and right, respectively;
1G for quantification; and S7 for larger fields of view), which are
Figure 1. Neuronal Conversion of Human
Fibroblasts by MicroRNAs and Striatal Fac-
tors
(A) Quantification by immunostaining of the syn-
ergistic effect of miRNAs and striatum-enriched
factors represented by the percentage of human
postnatal fibroblasts positive for MAP2, GABA,
and DARPP-32 after 35 days of being transduced
with miR-9/9*-124 in conjunction with striatum-
enriched factors. On the right, diagram repre-
senting the ability of miR-9/9*-124 to generate
striatal MSNs when combined with CTIP2, DLX1,
DLX2, and MYT1L (CDM). (See Figure S3 for im-
ages of reprogrammed cells and other combina-
tions attempted.)
(B) Expression of pan-neuronal markers, MAP2
(left), TUBB3 (middle), and NeuN (right) after
neuronal conversion of human postnatal dermal
fibroblasts with miR-9/9*-124 combined with
transcription factors CDM. Larger scale views.
Scale bar, 20 mm.
(C) Quantification of MAP2-, NeuN-, and TUBB3-
positive cells for DAPI signals from randomly
picked fields of view. For MAP2 and TUBB3
quantification, only the cells with processes at least
three times the length of the cell body were coun-
ted positive. MAP2: n = 207 cells; TUBB3: n = 328
cells; NeuN: n = 328 cells. The error bars are in SD.
(D) Expression of SCN1a and Synapsin 1 in miR-9/
9*-124-CDM-converted cells. Scale bar, 20 mm.
(E) Human postnatal fibroblasts transduced with
CDM factors in the absence of miR-9/9*-124 did
not generate neurons after 35 days, demon-
strating the requirement of miR-9/9*-124 for
neuronal conversion of human fibroblasts. Scale
bar, 20 mm.
(F and G) Expression of markers of GABAergic
MSNs. GABA ([E], top left) and GAD67 ([E], top
right). FOXP1 ([E], bottom left), DLX5 ([E], bottom
right), and DARPP-32 (G) are proteins enriched in
MSNs. The inset represents a magnified view of
(G). The graph (in [G], bottom left) represents
quantification of GABA, FOXP1, DLX5, and
DARPP-32 expression in MAP2-positive cells.
GABA: n = 474 cells; FOXP1: n = 232 cells; DLX5:
n = 207 cells; DARPP-32: n = 260 cells. The error
bars are in SD. Figures S5 and S7 provide larger
overviews of these markers as well as GABAergic
DARPP-32-positive cells and controls.
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et al., 2003; Stenman et al., 2003; Tamura et al., 2004). In addi-
tion, we found that the endogenous DLX1 was also expressed
in cells converted by miR-9/9*-124-CDM (Figure S8). Reprog-
ramming human fibroblasts using miR-9/9*-124 with DLX1/2
and MYT1L but without CTIP2 yielded highly GABAergic
neurons that were completely devoid of DARPP-32 expression
(Figure S9).
Interestingly, overexpression of CTIP2 (BCL11B) has been
shown to protect hematopoietic progenitor cells from apoptosis,
partially through the activity of members of the BCL2 family,
including Bcl-xL (Albu et al., 2007). We therefore tested if ectop-
ically expressing CTIP2 would induce the expression of Bcl-xL
but found no significant changes (Figure S4).Single-Cell Gene Expression Profiling
To further characterize the converted cells, we performed multi-
plex gene expression analyses in single cells to determine the
enrichment of neuronal subtypes. Single cells induced frompost-
natal human fibroblasts were collected at 5 weeks posttransduc-
tion and identified based on the expression of housekeeping
genes, GAPDH, RSP18, and HPRT1 (Figure 2A, left marked by
green dendrogram; n = 76 cells). Consistent with our immuno-
staining data, we found that the majority of the induced cells
were positive for gene products expressed in neurons including
MAP2, TUBB3, and MAPT, as well as components of voltage-
gated sodium channels (SCN2A and SCN3A), neural cell adhe-
sion molecule (NCAM1), neuronal ankyrin (ANK2), brain-derived
neurotrophic factor (BDNF), and the synapse-associated proteinNeuron 84, 311–323, October 22, 2014 ª2014 Elsevier Inc. 313
Figure 2. Single-Cell Gene Expression Anal-
ysis of Converted Cells and of Medium
Spiny Neurons Microdissected from Human
Adult Striatum
(A) Heatmap representation of multiplex qPCR of
76 converted cells (left) and 33 cells micro-
dissected from postmortem human putamen
sections (right). Each dot on top represents an
individual cell and color-coded dendrograms
denote genes of specific brain regions and cell
types described in (B). Top illustrations represent
the miR-9/9*-124-CDM-mediated neuronal con-
version (left) and single-cell laser-microdissection
of cresyl violet-stained human striatum sections
(right).
(B) Quantification of percentages of converted
cells and hMSNs for gene expression of specific
neuronal types. Ubq: ubiquitous; Neuronal: genes
generally expressed in neurons; Dp: dopa-
minergic; Ch: cholinergic; Gl: glutamatergic; Sr:
serotonergic; GABA/MSN: GABAergic MSNs;
GABA/Inter: GABAergic interneurons; Cb: cere-
bellum; P: peripheral nervous system; Prog: neural
progenitors; Crx: cortical; Sy: presynaptic; Ptch:
striatal patch. Figure S10 uses a pairwise com-
parison of these two sample groups to quantify the
degree of similarity of gene expression profile.
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dendrogram, and 2B, red bars). Interestingly, we did not detect
the expression of doublecortin (DCX), a marker of immature,
migratory neurons (Karl et al., 2005), suggestive of the maturity
of the induced neurons. Importantly, miR-9/9*-124-CDM-
induced cells were devoid of markers of dopaminergic neurons
(DBH,DDC,DAT, and TH), cholinergic neurons (CHAT), glutama-
tergic neurons (VGLUT2 andVGLUT3), and serotonergic neurons
(SERT, TPH2,HTR2C, andHTR3A) (Figures 2A, left, gray dendro-
gram, and 2B). Instead, the majority of converted cells were pos-
itive for GABAergic markers (GAD1/GAD2) and DARPP-32 (also
known asPPP1R1B) in agreementwith our immunostaining data.
We also detected expression of genes associated with striato-
nigral (DRD1, CHRM4, and TAC1) and striatopallidal (DRD2,
PENK, and GPR6) MSNs (Lobo et al., 2006) as well as transcrip-
tion factors RARB and POU3F1 (Figures 2A, left, red dendro-
gram, and 2B). SHANK3, which has been shown to be important
for the synaptic function ofMSNs (Pec¸a et al., 2011), was also ex-
pressed in a high fraction of the converted cells. Interestingly, we
did not detect expression of genes enriched in striatal patch neu-
rons (OPRM1 and PDYN) (Gong et al., 2003; Pert et al., 1976) in
the converted cells. This suggests that the converted MSNs are
likely to be of the striatal matrix (Figure 2B), which constitutes
about 85% of the volume of the striatum (Johnston et al.,
1990), consistent with the role of DLX1/2 in specifying matrix
neurons (Anderson et al., 1997).
Human Striatum Laser Microdissection
To compare the gene expression profile of the converted cells to
primary striatal neurons in the human brain, we analyzed human
striatal cells collected by laser capture microdissection (LCM)
from human postmortem adult striatal sections using the same
set of assay primers. Consistent with the notion that the striatum314 Neuron 84, 311–323, October 22, 2014 ª2014 Elsevier Inc.is highly populated withMSNs (Gerfen, 1992), we detected that a
large percentage of microdissected cells expressed DARPP-32.
In addition, LCM samples expressed CTIP2, DLX1, DLX2, and
MYT1L, and the overall gene expression profile was analogous
to miR-9/9*-124-CDM-induced neurons (Figures 2A, right panel,
and 2B, blue bars) (Figure S10 for pairwise comparison of LCM
and reprogrammed MSNs). Importantly, miR-9/9*-124-CDM
generated a homogenous population of MSNs, as we did not
detect the expression of genes exclusive to striatal or cortical
GABAergic interneurons (SST, PVALB, Calretinin, LHX6, and
NKX2-1) (Marin et al., 2000; Tepper et al., 2010) (Figure 2). In
both sets of data, genes enriched in the cerebellum (PCP2 and
GRP), peripheral nervous system (PRPH), neural progenitors
(EOMES, NES, ASCL1, and PAX6), and in cortical neurons
(TBR1, NEUROD1, P75NTR, OTX1, and OTX2) were also largely
undetectable (Figure 2). Finally, a pairwise comparison of the
expression of genes tested between the reprogrammed cells
and microdissected human MSN (hMSN) indicated a strong cor-
relation with a coefficient of determination (R squared) value of
0.77 (Figure S10). We also found miR-9/9* and miR-124 to be
highly expressed in the human striatum (Figure S11), consistent
with the expression of endogenous miR-9/9*-124 in converted
MSNs (Figure S2).
Functional Properties of Reprogrammed hMSNs
in Tissue Culture
The striatal circuitry is exceptionally intricate as it converges in-
puts from several brain regions with distinctive neurotransmit-
ters, such as glutamatergic input from cortex and thalamus,
dense dopaminergic innervation from substantia nigra, and local
cholinergic and GABAergic inhibition (Graybiel et al., 1994).
Many of these inputs have been shown to contribute to shaping
the membrane properties and functional maturation of MSNs.
Figure 3. Electrophysiological Characteristics of Converted
Medium Spiny Neurons in Tissue Culture
(A) Whole-cell current-clamp recording of MSNs converted from postnatal
human fibroblasts. Converted human cells were cocultured with neonatal rat
glia and displayed multiple APs in response to step current injections at
6 weeks posttransduction. All cells recorded (n = 12) fired APs in response to
current injections.
(B) Representative traces of fast-inactivating inward currents recorded in
voltage-clamp mode and blocked by 300 nM TTX. Voltage steps ranged
from +10 to +70 mV.
(C andD) Increased complexity of AP spikes of converted cellswhen cocultured
with glia. EGFP-tagged cells converted from postnatal fibroblasts were re-
cordedat 6or 12weeksposttransduction. At 6weeks, cellswere recorded in the
absence (monoculture) or presence of rat primary glia (coculture) (C). In mo-
noculture, the majority of cells showed single spikes at 6 weeks posttrans-
duction, whereas a larger percentage of cells recorded at 12 weeks generated
repetitive APs. When cocultured with primary glia, all cells fired repetitively at
6 weeks (D). Intrinsic membrane properties are provided in Table S1.
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(PV-FSI) and neuropeptide-Y positive low-threshold spiking in-
terneurons (NPY-LTS) have been shown to form synaptic con-
nections with MSNs and regulate their firing activity (Do et al.,
2012; Koo´s and Tepper, 1999). Therefore, MSNs can be distin-
guished in vivo not only due to their biochemical and anatomical
differences but also by their intrinsic physiological properties.
MSNs have been shown to rest at a hyperpolarized membrane
potential (80 mV to 90 mV), significant inwardly rectifying K+
currents at or below resting membrane potentials, and a firing
pattern with long delays to the initial action potential (AP) with lit-
tle or no spike frequency accommodation (SFA) (Gertler et al.,
2008; Venance and Glowinski, 2003). To examine the generic
neuronal electrophysiological properties as well as MSN-spe-
cific properties in cells converted by miR-9/9*-124-CDM in tis-
sue culture, we performed whole-cell patch-clamp recordings
at 6 weeks posttransduction in converted cells cultured with
rat primary glia. We found that all converted cells elicitedmultiple
APs upon the injection of depolarizing currents (Figure 3A) and
large fast-inactivating inward currents followed by outward po-
tassium currents when evoked by a series of voltage steps (Fig-
ure 3B) (see Table S1 for intrinsic membrane properties) (n = 12).
Inward currents were ablated upon local perfusion of tetrodo-
toxin (TTX) (300 nM), indicating that they were mediated via
TTX-sensitive voltage-gated sodium channels (Figure 3B). To
test the ability of converted cells to become electrically active
in the absence of primary glia, we decided to investigate the
membrane properties of our cells cultured in isolation (monocul-
ture). Surprisingly, converted neurons were also capable of firing
APs and displayed functional maturation over time in culture.
Whereas the converted cells initially displayed modest APs at
6 weeks, a much more complex firing pattern with nearly 50%
of the recorded cells firing repetitively was evident at 12 weeks
posttransduction (shown in Figure 3D). In addition, converted
cells displayed significantly larger peak amplitudes of inward
currents at 12 weeks, correlated with increased excitability
(see Figure S12 and Table S1 for additional traces and mem-
brane properties). Since one of the major inputs impinging
upon MSNs in vivo are excitatory glutamatergic afferents from
the cerebral cortex (Kreitzer, 2009), we investigated if coculturing
the converted cells with rat cortical neurons would lead to the
formation of functional synapses. As seen by the synaptic cur-
rents (Figure 3E) (8 out of 13 total cells recorded), reprogrammed
MSNs successfully mature into synaptically active neurons.
In addition to determining that the reprogrammed cells are(E) Representative trace of spontaneous postsynaptic currents from cocul-
tured cells recorded at 12 weeks.
(F) Deconstructed traces from current-clamp recording shown in (A). The first
spike event, followed by sequential steps is shown from left to right. Arrow
denotes a latency to the initial spike characteristic of MSNs.
(G) Representative traces of inward rectifying currents generated from whole-
cell voltage-clamp recording. Cells were stimulated with voltage steps ranging
from 120 mV to +20 mV in 10 mV increments.
(H) Current levels at steady state were measured and plotted against holding
voltages to generate an I-V curve fitted with a cubic spline curve (displayed in
red) (n = 7).
(I) Resting membrane potentials of recorded cells (n = 12). Box and whisker
plot is shown to represent the median as well as the greatest and lowest value.
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Figure 4. Conversion of Adult Human Fibro-
blasts Mediated by miR-9/9*-124 and Inde-
pendent of ASCL1
(A) Expression of neuronal markers andmarkers of
MSNs converted from adult human fibroblast (42
years old) transduced with miR-9/9*-124 + CDM.
MAP2 (top left), TUBB3 (top right), GABA (bottom
left), and DARPP-32 (bottom right).
(B) miR-9/9*-124-mediated neuronal reprogram-
ming does not induce ASCL1 expression in human
adult fibroblasts.miR-9/9*-124-expressing human
adult fibroblasts were analyzed by qPCR at post-
infection day (PID) 14, 21, and 30 for ASCL1
expression. As a positive control, a separate
preparation of human fibroblasts was transduced
with ASCL1 cDNA, and RNA was collected after
48 hr. N.D., not detected. Error bars = SEM.
(C) Testing whether ASCL1 could substitute miR-
9/9*-124 for neuronal reprogramming of human
adult fibroblasts. Human adult fibroblasts were
transduced with either miR-9/9*-124 + CDM (top
pictures) or ASCL1 + CDM (bottom pictures) and
immunostained for MAP2 at PID 14, 21, and 30.
Based on the observation that MAP2-positive
neuronal cells were largely absent in ASCL+CDM
condition, miR-9/9*-124 is not interchangeable
with ASCL1.
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Induction of Human Fibroblasts to Striatal Neuronsexcitable, we also detected long delays to initial spike (Figure 3F)
(6 out of 12 total cells recorded), a typical firing pattern of MSNs,
whereas we only detected modest inward rectification (shown in
Figure 3G and quantified in Figure 3H). We found that the degree
of hyperpolarized resting membrane potential wasminimal in tis-
sue culture (58.35 mV ± 3.08). The functional maturation of our
cells from 6 to 12 weeks in monoculture (Figure S12) suggests
that perhaps achieving a significantly hyperpolarized resting
membrane potential requires longer culturing conditions.
Consistently, MSNs from dissociated mouse striatal cultures
have been shown to develop more negative membrane poten-
tials with time in vitro (Lalchandani and Vicini, 2013).
Conversion of Adult Human Fibroblasts
Direct reprogramming of human postnatal and adult somatic
cells into neurons has proved to be more challenging than re-316 Neuron 84, 311–323, October 22, 2014 ª2014 Elsevier Inc.programming murine cells (Banito et al.,
2009; Zhang et al., 2013). We asked
whether the miR-9/9*-124-CDM-based
approach could convert adult human fi-
broblasts into MSNs. We found that adult
human dermal fibroblasts derived from a
42-year-old individual could be success-
fully converted into neurons with 82% of
the cells being positive for MAP2 expres-
sion (n = 405 total cells) (representative
image in Figure 4A). Consistent with the
postnatal cells, the majority of adult cells
were also GABAergic (86%, n = 147 total
cells) and expressed DARPP-32 (77%,
n = 333 total cells) (Figure 4A). In fact,we found that miR-9/9*-124 could reprogram human fibroblasts
from multiple individuals independent of the donor’s age with a
similar efficiency (Figure S3).
The direct conversion of mouse fibroblasts into induced neu-
rons has been reported with three transcription factors, BRN2,
ASCL1, and MYT1L (Vierbuchen et al., 2010), while others
have reprogrammed embryonic and fetal human fibroblasts
with the same factors but supplemented with NeuroD1 (Pang
et al., 2011; Son et al., 2011). Working solely with human
postnatal fibroblasts, we showed that miR-9/9*-124 in combina-
tion with ASCL1, NEUROD2, and MYT1L successfully reprog-
ramed fibroblasts into functional neurons (Yoo et al., 2011).
The role for ASCL1 in direct neuronal reprogramming (Caiazzo
et al., 2011; Pang et al., 2011; Yoo et al., 2011) has recently
been reported to be due in part to its activity as a pioneer
transcription factor (Wapinski et al., 2013), and we asked if
Figure 5. Engraftment and Long-Term Sur-
vival of Transplanted MSNs In Vivo
(A) A diagram illustrating our cell transplantation
protocol. Human adult dermal fibroblasts were
collected and cultured from a 22-year-old indi-
vidual and transduced with lentivirus to express
miR-9/9*-124 and CDM factors. At 2 days post-
transduction, cells were transduced with addi-
tional lentivirus to label human cells with EGFP. At
2 weeks posttransduction, cells were harvested
and transplanted into the striatum of NOD scid
gamma immunodeficient mice.
(B) A low magnification of a coronal brain section
showing transplanted human cells labeled with
EGFP residing in the striatum. Scale bar, 80 mm.
The inset displays a reconstruction of the coronal
brain section with DAPI in blue.
LV, Lateral ventricle. STR, Striatum.
(C) Low- and high-magnification views of EGFP-
positive cells in situ for 3.5 and 6.5 months post-
transplantation. Scale bar, 10 mm.
(D) Expression of EGFP, MAP2, and DARPP-32.
Arrows mark cells coexpressing all three markers.
Scale bar, 10 mm.
(E) Quantification of MAP2, GABA and DARPP-32,
and FOXP1-positive cells for EGFP-expressing
cells. MAP2: n = 203 cells; GABA: n = 174 cells;
DARPP-32: n = 173 cells; FOXP1: n = 173 cells.
Error bars are in SD.
(F) Expression of FOXP1, GABA, and CTIP2 in
miR-9/9*-124-CDM. Inset highlights dendritic
spines. Scale bar, 10 mm.
Neuron
Induction of Human Fibroblasts to Striatal NeuronsmiR-9/9*-124-mediated reprogramming involved the activity of
ASCL1. We transduced human adult fibroblasts with miR-9/9*-
124 to determine if ASCL1 expression would be induced and
found ASCL1 expression to be undetectable upon the expres-
sion of miR-9/9*-124 at posttransduction days 14, 21, and 30
(Figure 4B). We also attempted to reprogram human adult fibro-
blasts intoMSNswith CDM factors in conjunction with ASCL1. In
comparison tomiR-9/9*-124-CDM, ASCL1-CDMgenerated very
fewMAP2-positive cells that lacked neuronal morphologies (Fig-
ure 4C). Collectively, these findings indicate that miR-9/9*-124-
mediated neuronal reprogramming is independent of the activity
of ASCL1.
Functional Integration of Converted MSNs In Vivo
Next, we tested the ability of adult-derived cells to survive and
differentiate in vivo by transplanting reprogrammed hMSNsNeuron 84, 311–323,into the mouse striatum. Adult fibroblasts
were transduced with miR-9/9*-124-
CDM and labeled with EGFP. Cells were
harvested 2 weeks posttransduction, in-
jected unilaterally into the striatum of
immunodeficient mice and analyzed at
day 50 after transplantation (DAT) (Fig-
ure 5A) (n = 14). EGFP-positive cells
were detected in the dorsal striatum adja-
cent to the lateral ventricle (Figure 5B).
Remarkably, we regularly detectedEGFP cells in mice even after 3.5 and 6.5months, demonstrating
the stable conversion and long-term survival of the reprog-
rammed cells (Figure 5C). EGFP-marked cells were 93% MAP2
positive (n = 203), 76% GABAergic (n = 174), 91% DARPP-32
positive (n = 173), and 91% FOXP1 positive (n = 173) (Figures
5D, 5E, and 5F). Moreover, transplanted cells exhibited dense
dendritic spines (Figure 5F, right).
Membrane Properties of Converted MSNs In Vivo
We assessed the functional properties of reprogrammed hMSNs
in vivo in comparison to native mouse MSNs (mMSNs) using
whole-cell recordings in acute striatal slices at 112 DAT (Fig-
ure 6A). A total of 18 cells were targeted for recordings, including
11 non-EGFP mMSNs and 7 EGFP-positive hMSNs. Native
mMSNs were identified and distinguished from striatal interneu-
rons based on their characteristic membrane properties and APOctober 22, 2014 ª2014 Elsevier Inc. 317
Figure 6. Functional Properties of Transplanted hMSNs in Comparison to mMSNs
(A and B) A total of 18 cells (7 EGFP-positive human cells and 11 non-EGFP mMSNs) were recorded from brains slices prepared at 16 weeks posttransplantation
to compare membrane properties between reprogrammed human and mMSNs. AP trains were evoked by injecting current steps in EGFP-positive human cells
(A) and mMSNs (B). The photograph depicts a representative image of whole-cell recording from an EGFP-positive cell in a striatal slice. Insets on the right show
deconstructed traces of the first AP recorded, progressing from bottom to top. The arrows shown in the insets demonstrate delay to the initial spike, characteristic
of MSNs. All 18 recorded cells were capable of generating repetitive APs.
(legend continued on next page)
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Induction of Human Fibroblasts to Striatal Neuronsfiring patterns (Tepper et al., 2010). We found that all cells we
examined (hMSNs and mMSNs) were able to fire AP trains
when evoked by current steps and displayed long delays to initial
AP spike (shown in the inset of Figures 6A and 6B and quantified
in Figure 6I). Strong inward rectification, also characteristic of
MSNs, was observed by an injection of voltage-ramp (Figure 6C
for hMSNs and Figure 6E for mMSNs). The corresponding cur-
rent-voltage relationship (I-V curve) was also identical between
hMSNs and mMSNs (Figure 6K). Furthermore, we examined
the AP threshold using a current-ramp protocol (Figure 6D for
hMSNs and Figure 6F for mMSNs) and found no significant dif-
ference between the two cell types (Figure 6I). We then assessed
whether transplanted cells were able to incorporate into local cir-
cuits by examining spontaneous postsynaptic potentials
(sPSPs), which represent the network activity of surrounding
neurons that form functional synapses onto hMSNs. As shown
by the representative traces in Figures 6G and 6H, sPSPs were
readily detected in all hMSNs (7 out of 7) and mMSNs (11 out
of 11) with no significant difference in the sPSP frequency (Fig-
ure 6I), providing further evidence that transplanted cells could
integrate into functional circuits in vivo. Additionally, we found
that the resting membrane potentials of hMSNs were hyperpo-
larized (83.29 mV ± 2.40) in hMSNs, similar to native mMSNs
(85.20 mV ± 1.67) (Figure 6I). We quantified the SFA ratio by
calculating the frequency of the first spike (Finitial) in relation to
the frequency of the average of the last two spike intervals (Ffinal),
as previously reported (Venance and Glowinski, 2003). We found
that both hMSNs andmMSNs displayed little to no spike accom-
modation with SFA values close to 1 (Figure 6J). Essentially, all
membrane properties characteristic of MSNs that we analyzed
were similar between transplanted and native MSNs during
ex vivo recordings (Figure 6I).
Formation of Axonal Projections by Transplanted MSNs
Striatal MSNs give rise to projections terminating in two distinct
nuclei within the basal ganglia, the globus pallidus and the sub-
statia nigra, and these pair of nuclei in turn forms the two major
striatal output systems (Gerfen, 1992). We therefore investigated
whether transplanted hMSNs could extend projections into these
distal targets of endogenous MSNs. Remarkably, we found
EGFP-positive projections extending from the injection site in
the dorsal striatum to the substantia nigra (six out of six brains
analyzed at 56–64 DAT) with axon terminals also visible in the
globus pallidus (Figure 7A). This finding signifies not only that re-
programmed hMSNs are capable of long distance axonal
outgrowth but also that they recognize and follow axonal guid-(C–F) Voltage ramp protocol from 150 mV to +30 mV shows inward rectification
depolarized in reprogrammed human cells (C) and mMSNs (E). Large inward cur
measured by assessing APs occurring with steady-state current injections in repr
(G and H) Representative traces of sPSPs recorded from transplanted human cell
displayed spontaneous PSPs. sPSP frequencies are quantified in the last graph
(I) Comparative analyses of active and passive membrane properties between hM
properties, including input resistance, resting membrane potential (Vrest), AP th
quencies shown in (G) and (H). Individual data points are presented to show the d
significant by student t test.
(J) A representative AP trace from a hMSN illustrating the frequency ratio (finitial/ffina
right shows no significant difference between hMSNs and mMSNs. Data presen
(K) I-V curves for hMSNs in green and mMSNs in gray, demonstrating large inwaance cues intrinsic to striatal projection neurons. Interestingly,
although transplanted hMSNs are mostly confined within 1 mm
of the injection site (Figure 7B), we observed that a small number
of cells (4.7%; n = 2,770 cells) could be found beyond the striatal
boundary (Figure 7C). Due to the required transduction of multiple
lentiviral vectors, we suspected that cells adopting positions
outside the striatum lacked the expression of one ormore factors.
We found that while the vast majority of our EGFP-positive cells
residing within the striatum expressed CTIP2, the occasional
EGFP-positive cells found outside the striatum mostly lacked
the expression of CTIP2 (92.3% n = 332) (Figure 7C). Since
CTIP2 is highly expressed in the striatumas seenby immunostain-
ing (Figure 7D), this finding may suggest that expression of CTIP2
may be important for determining migratory boundaries for cells
destined to become MSNs within the developing striatum.
DISCUSSION
In this study, we describe a method to directly convert human
postnatal and adult fibroblasts into a highly enriched population
of striatal MSNs, the main cell type affected in Huntington’s dis-
ease. We find that our direct reprogramming approach offers an
unprecedented technological advance in time and homogeneity
of generating DARPP-32-positive neurons in comparison to cells
derived from iPSCs (HD iPSC Consortium, 2012; Zhang et al.,
2010). In addition, we show that the reprogrammed cells have
an analogous gene expression profile to primary hMSNs
captured by laser microdissection and, when transplanted into
the murine striatum, can functionally integrate into the local cir-
cuit, persist in situ for over 6 months, and send projections to
correct anatomical targets. In previous studies, directly re-
programmed human neurons exhibited decreased competence
for synapse formation, which hampered their use in disease
modeling and made differentiating iPSCs or embryonic stem
cells into neuronsmore appealing (Zhang et al., 2013). In our cur-
rent study, we present evidence that miRNA-dependent direct
reprogramming generates functional neurons readily capable
to form synapses in vivo. Lastly, our results demonstrate that
miR-9/9*-124-CDM-mediated derivation of MSNs from human
skin fibroblasts is efficient and consistent in multiple samples
from postnatal to adult individuals.
The authenticity of our converted MSNs is likely due to the
combinatorial code for gene expression generated by miR-9/
9*-124-CDM, which resembles the endogenous cell differentia-
tion program of MSNs. We paid particular attention to factors
that could be instructive in defining different stages of the striatalat hyperpolarized membrane potentials and outward currents as cells become
rents can be seen as the cell reaches AP threshold (arrows). AP threshold was
ogrammed hMSNs (D) and mMSNs (F). Arrows demonstrate the onset of APs.
s (G) and mMSNs (H). Seven out of seven EGFP-positive cells, and all mMSNs,
of (I).
SNs and mMSNs. Similar membrane properties were observed in all quantified
reshold, delay time to initial spikes, current steps to initial spike, and PSP fre-
egree of deviation from the mean. Histogram shown as mean ± SEM. N.S., not
l) to determine SFAs, quantified at 40 pA above AP threshold. Histogram on the
ted as mean ± SEM.
rd rectifications at hyperpolarized membrane potentials for both cases.
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Figure 7. Establishment and Targeting of
Axonal Projections by Transplanted HMSNs
(A) Midsagittal brain section immunostained with
tyrosine hydroxylase in red labeling cell bodies in
the substatia nigra (SN) and its dense innervation
of the striatum (STR). EGFP-positive cells and
dendrites can be seen dispersed throughout the
dorsal striatum with projections extending to
globus pallidus (GP) and substantia nigra (SN) in
green. Scale bar, 300 mm.
(B) Quantification of cell migration in the medial-
lateral axis from the injection site represented in
the histogram as 0 mm. n = 3 animals with a total of
2,770 cells counted.
(C and D) The vast majority of EGFP-positive cells
were confined within the striatum (95.3%), while a
small population of cells was found beyond the
striatal boundary (n = 2,770 cells counted for
striatum versus outside) (C). While the vast ma-
jority of the EGFP-positive cells within the striatum
were CTIP2 positive, nearly all the EGFP-positive
cells found outside of the striatum lacked the
expression of CTIP2 (quantified in the gray are of
the pie chart in [C] and pictured in [D]). n = 332
cells. Scale bar, 30 mm. Error bars = SEM.
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Induction of Human Fibroblasts to Striatal Neuronscell lineage. For example, the expression of DLX1/2 in the
absence of ASCL1 is known to form GABAergic neurons that
originate from the same birthplace as MSNs, the ganglionic
eminence of the ventral forebrain (Letinic et al., 2002). Later, as
MSNs migrate away from the ganglionic eminence into the stria-
tum, CTIP2 begins to be expressed and is maintained at high
levels throughout adulthood (Arlotta et al., 2008). Similarly, the
cells undergoing neuronal reprogramming were likely poised to
a neuronal state by miR-9/9*-124 and MYT1L and refined to
adopt a fate analogous to MSNs by the instruction of DLX1/2
and CTIP2. This process can be compared to a recent proposal
that the attainment of a stable neuronal cell identity occurs in
progressive steps in which a common neuronal identity is estab-
lished first, and only after the initiation of refinement programs, a
neuron becomes terminally differentiated (Fishell and Heintz,
2013). Similarly, we postulate that miR-9/9*-124 drives human fi-
broblasts into a neuronal state that can be further modulated by
the instruction of lineage-specific fate determinants. This miR-9/
9*-124-induced neuronal state can be characterized by (I) induc-
tion of proliferative cells to become post-mitotic, (II) acquisition
of neuronal morphology, (III) induction of broadly expressed
neuronal markers (MAP2, TUBB3, and NeuN) lacking markers
of neuronal subtypes, (IV) induction of compositional changes
in the neuron-specific BAF (nBAF) chromatin remodeling
complexes (Staahl et al., 2013; Yoo et al., 2009), and lastly, (V)
suppression of factors that antagonize the expression of
neuron-specific genes, such as the RE1-silencing transcription320 Neuron 84, 311–323, October 22, 2014 ª2014 Elsevier Inc.factor (REST/NRSF) and PTBP1 (Boutz
et al., 2007; Conaco et al., 2006; Makeyev
et al., 2007; Packer et al., 2008; Xue et al.,
2013). In our current study, the overex-
pression of CDM was only capable of
generating neurons when coexpressedwith miR-9/9*-124, suggesting that these miRNAs promote a
neuronal state permissive for the activity of terminal fate determi-
nants. We postulate that this neuronal state may be, at least
partially, due to the ability of miR-9/9*-124 to alter the chromatin
landscape of non-neuronal cells during neural induction.
Namely, miR-9/9* and miR-124 have been shown to regulate
the activity of REST/NRSF complex (Packer et al., 2008; Visva-
nathan et al., 2007), which blocks the expression of neuronal
genes in non-neuronal cells by recruiting and assembling amulti-
meric repressor complex composed of epigenetic regulatory
factors (Ballas and Mandel, 2005). Therefore, the ectopic
expression of miR-9/9*, which directly suppresses REST/
NRSF, and miR-124, which targets the antineural factors
PTPB1 and SCP1, results in activation of neuronal genes (Make-
yev et al., 2007; Packer et al., 2008; Visvanathan et al., 2007).
Importantly, miR-9/9*-124 orchestrate the switch of subunits of
BAF chromatin remodeling complexes to promote a nBAF com-
plex, an evolutionarily conserved process crucial for postmitotic
neural development and dendritic morphogenesis (Yoo et al.,
2009). It is interesting to note that REST-mediated neuronal
gene repression has been demonstrated to be dependent on
the activity of the BAF chromatin-remodeling complexes (Batta-
glioli et al., 2002). Even more intriguingly, CTIP2 (BCL11B) has
recently been found to be a dedicated and stable subunit of
the BAF complex (Kadoch et al., 2013). The ectopic expression
of miR-9/9*-124 in conjunction with CTIP2 therefore is likely to
shape the activity of the BAF complex and could potentially
Neuron
Induction of Human Fibroblasts to Striatal Neuronsexplain our robust reprogramming toward a DARPP-32-positive
cell fate, although this remains speculative. Collectively, the
changes mediated by miR-9/9*-124 poise the cell to adopt a
neurogenic state that can be influenced by lineage-specific tran-
scription factors to guide neuronal conversion toward specific
subtypes, as demonstrated in our study.
Moreover, we observed that several individual transcription
factors besides CDM factors could robustly generate MAP2-
positive human cells with miR-9/9*-124, although the subtype
identify of these neurons are yet to be determined (Figure S3).
This finding raises the possibility of simply fine-tuning the
composition of additional transcription factors to generate
various neuronal subtypes. Since our current study suggests
that miR-9/9*-124-mediated reprogramming is independent of
ASCL1, miR-9/9*-124-based reprogramming may be beneficial
for inducing neuronal subtypes that do not contain ASCL1 in their
endogenous differentiation program. Alternatively, ASCL1 may
be combined with miR-9/9*-124 to derive neuronal subtypes
where ASCL1 is involved in terminal differentiation. In summary,
our study utilizing the neurogenic activities of microRNAs and
transcription factors demonstrates an important step toward
generating human neurons of a specific neuronal subtype, an
experimental approach of extreme importance when studying
neurological diseases affecting specific neuronal subtypes and
brain regions.EXPERIMENTAL PROCEDURES
Cell Culture
Lentiviral preparation of a Dox-responsive synthetic cluster of miR-9/9* and
miR-124 (Yoo et al., 2011), as well as transcription factors cloned downstream
of the EF1a promoter, was used to transduce human postnatal or adult fibro-
blasts (ATCC and ScienCell). The following cell line was obtained from the
NIGMS Human Genetic Cell Repository at the Coriell Institute for Medical
Research: GM02171 and used for data shown in Figures 5 and S3 (C). Typi-
cally, infected human fibroblasts were maintained in fibroblast media for
2 days with Dox before replating onto coated coverslips. Cells were then
selected with appropriate antibiotics in neuronal media (ScienCell) sup-
plemented with valproic acid (1 mM), dibutyryl cAMP (200 mM), BDNF
(10 ng/ml), NT-3 (10 ng/ml), and RA (1 mM). Dox was replenished every
2 days and media were changed every 4 days. A detailed reprogramming pro-
tocol is available in Supplemental Experimental Procedures.
Immunofluorescence
Cells were fixed using 4% paraformaldehyde or combined with 0.2% glutaral-
dehyde (both from Electron Microscopy Sciences) for 20 min at room temper-
ature (RT) followed by permeabilization with 0.2% Triton X-100 for 10 min. One
percent goat or donkey serumwas used for blocking followed by incubation of
primary antibodies overnight at 4C. Secondary antibodies conjugated to
Alexa-488, -594, or -647 were applied for 1 hr at RT. Detailed list of antibodies
used and the procedure for immunohistochemistry analysis can be found in
the Supplemental Experimental Procedures.
Single-Cell Quantitative PCR
Reprogrammed postnatal cells were harvested and single cells were collected
by FACS sorting 5 weeks posttransduction. Deidentified human striatal sec-
tions from postmortem autopsy samples were obtained in accordance with
the guideline of HRPO of Washington University School of Medicine. Postmor-
tem single cells stained with cresyl violet were laser dissected from striatal pu-
tamen tissue sections of an 89-year-old individual. Samples were used for
reverse-transcription and gene expression analysis using Fluidigm Dynamic
arrays (see Supplemental Experimental Procedures).Cell Harvesting and Transplantation
Reprogrammed cells were typically transduced with a Synapsin promoter-
EGFP lentivirus at reprogramming day 2 and harvested for transplantation
studies at reprogramming day 14. Adherent cell cultures were mechanically
dissociated and concentrated by centrifugation (4min at 1,000 RPM). Concen-
trated cell suspensions (104 cells/ml) were loaded into a 5 ml Hamilton syringe
(26 s/2/2 Gauge/Length/Point) and 2 ml injected into the right striatum of NSG
mice (P0 to P1).
Animals
Mice weremaintained in standard housing conditions with food and water pro-
vided ad libitum. All procedures followed the guidelines of theWashington Uni-
versity’s Institutional Animal Care and Use Committee (IACUC) and the Animal
Studies Committee (ASC).
Electrophysiology, Slice Preparation, and Recordings
Detailed methods and description of the composition of internal and external
solutions used for ex vivo recording can be found in the Supplemental Exper-
imental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes twelve figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2014.10.016.
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